Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hic1
|
ENSMUSG00000043099.4 | hypermethylated in cancer 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_75166966_75167344 | Hic1 | 991 | 0.334290 | 0.32 | 1.6e-02 | Click! |
chr11_75168044_75169075 | Hic1 | 413 | 0.684110 | 0.32 | 1.6e-02 | Click! |
chr11_75169730_75170036 | Hic1 | 364 | 0.715807 | 0.23 | 8.8e-02 | Click! |
chr11_75169094_75169322 | Hic1 | 311 | 0.771413 | 0.19 | 1.7e-01 | Click! |
chr11_75167503_75167654 | Hic1 | 568 | 0.560977 | 0.14 | 3.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_77564959_77566098 | 11.00 |
Rnf165 |
ring finger protein 165 |
367 |
0.89 |
chr9_106886021_106887464 | 10.10 |
Rbm15b |
RNA binding motif protein 15B |
686 |
0.53 |
chr10_32889642_32890523 | 9.86 |
Nkain2 |
Na+/K+ transporting ATPase interacting 2 |
234 |
0.95 |
chr8_23411129_23412450 | 9.33 |
Sfrp1 |
secreted frizzled-related protein 1 |
287 |
0.94 |
chr7_84409236_84410328 | 9.07 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
101 |
0.96 |
chr3_145987459_145988897 | 8.63 |
Syde2 |
synapse defective 1, Rho GTPase, homolog 2 (C. elegans) |
41 |
0.98 |
chr8_57321535_57322223 | 8.40 |
Hand2os1 |
Hand2, opposite strand 1 |
651 |
0.47 |
chr8_125569269_125570645 | 8.10 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
149 |
0.97 |
chr10_9674551_9675589 | 7.96 |
Samd5 |
sterile alpha motif domain containing 5 |
138 |
0.95 |
chr17_13759899_13761731 | 7.90 |
Afdn |
afadin, adherens junction formation factor |
141 |
0.73 |
chr8_127063794_127064607 | 7.85 |
Pard3 |
par-3 family cell polarity regulator |
45 |
0.97 |
chr12_112678481_112679637 | 7.84 |
Zbtb42 |
zinc finger and BTB domain containing 42 |
181 |
0.89 |
chr17_66448520_66450314 | 7.61 |
Mtcl1 |
microtubule crosslinking factor 1 |
333 |
0.57 |
chr13_72628074_72629485 | 7.53 |
Irx2 |
Iroquois homeobox 2 |
41 |
0.73 |
chr6_99692354_99692948 | 7.19 |
Gpr27 |
G protein-coupled receptor 27 |
28 |
0.97 |
chr18_36017856_36019112 | 7.18 |
Nrg2 |
neuregulin 2 |
13457 |
0.16 |
chr11_89302295_89302892 | 7.14 |
Gm2018 |
predicted gene 2018 |
130 |
0.68 |
chr2_157078595_157079557 | 7.07 |
Soga1 |
suppressor of glucose, autophagy associated 1 |
178 |
0.93 |
chr17_85687855_85689066 | 7.05 |
Six2 |
sine oculis-related homeobox 2 |
186 |
0.94 |
chr8_15027100_15028701 | 6.92 |
Gm37844 |
predicted gene, 37844 |
522 |
0.44 |
chr2_77816275_77817277 | 6.90 |
Zfp385b |
zinc finger protein 385B |
40 |
0.98 |
chr16_18620677_18621820 | 6.82 |
Gp1bb |
glycoprotein Ib, beta polypeptide |
392 |
0.75 |
chr6_119543741_119544508 | 6.79 |
Wnt5b |
wingless-type MMTV integration site family, member 5B |
194 |
0.95 |
chr12_103242082_103243024 | 6.72 |
Prima1 |
proline rich membrane anchor 1 |
403 |
0.85 |
chr7_64501527_64502724 | 6.64 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
13 |
0.98 |
chr4_114405732_114406986 | 6.06 |
Trabd2b |
TraB domain containing 2B |
365 |
0.93 |
chr13_83730468_83731674 | 5.94 |
Gm26803 |
predicted gene, 26803 |
1489 |
0.25 |
chr10_79681206_79682337 | 5.90 |
Cdc34 |
cell division cycle 34 |
424 |
0.63 |
chr5_65106807_65107827 | 5.87 |
Klhl5 |
kelch-like 5 |
222 |
0.92 |
chr15_85669900_85671551 | 5.76 |
Lncppara |
long noncoding RNA near Ppara |
17109 |
0.13 |
chr1_21960934_21962001 | 5.58 |
Kcnq5 |
potassium voltage-gated channel, subfamily Q, member 5 |
114 |
0.98 |
chr1_63445869_63446575 | 5.45 |
Adam23 |
a disintegrin and metallopeptidase domain 23 |
11 |
0.98 |
chr5_38158989_38159808 | 5.42 |
Nsg1 |
neuron specific gene family member 1 |
7 |
0.97 |
chr17_50292589_50293643 | 5.41 |
Dazl |
deleted in azoospermia-like |
224 |
0.93 |
chr18_82164402_82165095 | 5.30 |
Gm50294 |
predicted gene, 50294 |
93762 |
0.06 |
chr12_108422834_108423697 | 5.30 |
Eml1 |
echinoderm microtubule associated protein like 1 |
187 |
0.95 |
chr7_19473848_19474484 | 5.30 |
Gm45167 |
predicted gene 45167 |
5938 |
0.08 |
chr4_124656772_124657969 | 5.27 |
Gm2164 |
predicted gene 2164 |
201 |
0.77 |
chr14_120830371_120830865 | 5.25 |
Gm9391 |
predicted gene 9391 |
3460 |
0.2 |
chr10_31609196_31610069 | 5.22 |
Rnf217 |
ring finger protein 217 |
448 |
0.82 |
chr15_86033262_86033934 | 5.17 |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
605 |
0.74 |
chr12_80518528_80519832 | 5.17 |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
190 |
0.58 |
chr2_52857330_52857884 | 5.15 |
Fmnl2 |
formin-like 2 |
253 |
0.95 |
chr11_66526100_66526559 | 5.14 |
Shisa6 |
shisa family member 6 |
365 |
0.91 |
chr6_87980723_87981994 | 5.11 |
H1f10 |
H1.10 linker histone |
279 |
0.39 |
chr6_137648575_137649727 | 5.08 |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
78 |
0.98 |
chr14_115040506_115042372 | 5.08 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1440 |
0.19 |
chr18_82161587_82162228 | 5.05 |
Gm50294 |
predicted gene, 50294 |
96603 |
0.06 |
chr16_94526000_94527258 | 5.04 |
Vps26c |
VPS26 endosomal protein sorting factor C |
188 |
0.94 |
chr8_105170389_105171616 | 5.00 |
Cbfb |
core binding factor beta |
57 |
0.94 |
chr15_25364173_25365245 | 4.96 |
4930445E18Rik |
RIKEN cDNA 4930445E18 gene |
32050 |
0.14 |
chr17_71782235_71783145 | 4.96 |
Clip4 |
CAP-GLY domain containing linker protein family, member 4 |
73 |
0.97 |
chr6_99666291_99667273 | 4.94 |
Eif4e3 |
eukaryotic translation initiation factor 4E member 3 |
11 |
0.49 |
chr7_3414948_3415832 | 4.88 |
Gm23450 |
predicted gene, 23450 |
324 |
0.76 |
chr13_68998724_69000129 | 4.80 |
Adcy2 |
adenylate cyclase 2 |
115 |
0.87 |
chr10_122985267_122986641 | 4.72 |
D630033A02Rik |
RIKEN cDNA D630033A02 gene |
123 |
0.65 |
chr10_125388906_125389759 | 4.69 |
Slc16a7 |
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
36 |
0.95 |
chr4_108779892_108781170 | 4.69 |
Zfyve9 |
zinc finger, FYVE domain containing 9 |
28 |
0.97 |
chr2_61811420_61812187 | 4.57 |
Tbr1 |
T-box brain gene 1 |
5530 |
0.2 |
chr4_100776792_100777969 | 4.57 |
Cachd1 |
cache domain containing 1 |
705 |
0.79 |
chr10_83337112_83337951 | 4.53 |
Slc41a2 |
solute carrier family 41, member 2 |
91 |
0.96 |
chr3_132949340_132950694 | 4.51 |
Npnt |
nephronectin |
26 |
0.97 |
chr4_116877603_116878028 | 4.50 |
Zswim5 |
zinc finger SWIM-type containing 5 |
439 |
0.67 |
chr5_69340326_69341842 | 4.45 |
Gm24368 |
predicted gene, 24368 |
301 |
0.69 |
chr6_101377108_101377847 | 4.45 |
Pdzrn3 |
PDZ domain containing RING finger 3 |
135 |
0.96 |
chr13_73846884_73847811 | 4.43 |
Nkd2 |
naked cuticle 2 |
264 |
0.89 |
chr2_66124084_66125291 | 4.43 |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
307 |
0.72 |
chr12_117153628_117154553 | 4.32 |
Gm10421 |
predicted gene 10421 |
2439 |
0.42 |
chr4_48584803_48585524 | 4.29 |
Tmeff1 |
transmembrane protein with EGF-like and two follistatin-like domains 1 |
11 |
0.98 |
chr4_45184399_45185347 | 4.27 |
Frmpd1 |
FERM and PDZ domain containing 1 |
2 |
0.98 |
chr7_81933728_81934913 | 4.26 |
Hdgfl3 |
HDGF like 3 |
139 |
0.94 |
chr8_12756494_12757951 | 4.25 |
Atp11a |
ATPase, class VI, type 11A |
153 |
0.95 |
chr19_36553934_36555231 | 4.25 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
57 |
0.98 |
chr19_36057285_36057826 | 4.24 |
Htr7 |
5-hydroxytryptamine (serotonin) receptor 7 |
48 |
0.98 |
chr1_166308870_166309730 | 4.19 |
5330438I03Rik |
RIKEN cDNA 5330438I03 gene |
285 |
0.91 |
chr15_30172351_30173308 | 4.14 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
138 |
0.98 |
chr7_65155656_65156991 | 4.12 |
Fam189a1 |
family with sequence similarity 189, member A1 |
93 |
0.97 |
chr4_101068780_101069771 | 4.12 |
Raver2 |
ribonucleoprotein, PTB-binding 2 |
204 |
0.93 |
chr7_19094759_19096427 | 4.09 |
Six5 |
sine oculis-related homeobox 5 |
999 |
0.28 |
chr13_15462780_15463366 | 4.08 |
Gli3 |
GLI-Kruppel family member GLI3 |
162 |
0.76 |
chr16_37776737_37777678 | 4.08 |
Fstl1 |
follistatin-like 1 |
55 |
0.98 |
chr6_61179832_61181181 | 4.07 |
Ccser1 |
coiled-coil serine rich 1 |
31 |
0.76 |
chr1_93754379_93755416 | 4.07 |
Atg4b |
autophagy related 4B, cysteine peptidase |
8 |
0.5 |
chr2_54436378_54437149 | 4.05 |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
272 |
0.95 |
chr9_96888753_96890030 | 4.03 |
Pxylp1 |
2-phosphoxylose phosphatase 1 |
22 |
0.97 |
chr8_121652380_121653356 | 4.03 |
Zcchc14 |
zinc finger, CCHC domain containing 14 |
33 |
0.95 |
chr10_83648138_83649089 | 4.02 |
Appl2 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
10 |
0.98 |
chr13_31625869_31626532 | 4.02 |
Gm27516 |
predicted gene, 27516 |
343 |
0.37 |
chr12_86882228_86883612 | 4.00 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
1878 |
0.33 |
chr1_38626793_38628168 | 4.00 |
Aff3 |
AF4/FMR2 family, member 3 |
279 |
0.94 |
chr1_165281854_165282892 | 3.95 |
Gpr161 |
G protein-coupled receptor 161 |
13416 |
0.16 |
chr4_81442019_81442668 | 3.95 |
Mpdz |
multiple PDZ domain protein |
301 |
0.93 |
chr17_27203606_27204996 | 3.93 |
Lemd2 |
LEM domain containing 2 |
168 |
0.9 |
chr2_35621578_35622379 | 3.93 |
Dab2ip |
disabled 2 interacting protein |
3 |
0.98 |
chr8_121084168_121084657 | 3.92 |
Foxf1 |
forkhead box F1 |
26 |
0.79 |
chr16_28928734_28930302 | 3.92 |
Mb21d2 |
Mab-21 domain containing 2 |
155 |
0.97 |
chr1_25829654_25830461 | 3.90 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
350 |
0.61 |
chr10_18318282_18319172 | 3.86 |
Nhsl1 |
NHS-like 1 |
258 |
0.91 |
chr5_24601908_24602410 | 3.83 |
Smarcd3 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
147 |
0.91 |
chr8_32008598_32009895 | 3.83 |
Nrg1 |
neuregulin 1 |
64 |
0.99 |
chr1_92831123_92832495 | 3.83 |
Gpc1 |
glypican 1 |
160 |
0.92 |
chr3_103576080_103576684 | 3.82 |
Syt6 |
synaptotagmin VI |
240 |
0.92 |
chr19_16132209_16133500 | 3.79 |
Gnaq |
guanine nucleotide binding protein, alpha q polypeptide |
23 |
0.98 |
chr8_46210360_46210863 | 3.77 |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
419 |
0.73 |
chr7_100930787_100931664 | 3.75 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
882 |
0.51 |
chr3_86920207_86921011 | 3.71 |
Dclk2 |
doublecortin-like kinase 2 |
230 |
0.91 |
chr6_114968557_114970098 | 3.71 |
Vgll4 |
vestigial like family member 4 |
147 |
0.97 |
chr16_38742372_38743125 | 3.68 |
B4galt4 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4 |
427 |
0.78 |
chr7_3331892_3332177 | 3.65 |
Cacng7 |
calcium channel, voltage-dependent, gamma subunit 7 |
921 |
0.35 |
chr5_24474278_24475196 | 3.65 |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
523 |
0.59 |
chr7_57508956_57510254 | 3.62 |
Gabra5 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 |
234 |
0.95 |
chr2_38339333_38339958 | 3.59 |
Lhx2 |
LIM homeobox protein 2 |
157 |
0.94 |
chr10_116472994_116474473 | 3.58 |
Kcnmb4 |
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
145 |
0.69 |
chr5_115429294_115430226 | 3.57 |
Msi1 |
musashi RNA-binding protein 1 |
61 |
0.76 |
chr9_8003315_8004975 | 3.57 |
Yap1 |
yes-associated protein 1 |
245 |
0.79 |
chr3_9609034_9610646 | 3.56 |
Zfp704 |
zinc finger protein 704 |
245 |
0.94 |
chr3_154327918_154328874 | 3.56 |
Lhx8 |
LIM homeobox protein 8 |
230 |
0.93 |
chr16_22162976_22163893 | 3.55 |
Igf2bp2 |
insulin-like growth factor 2 mRNA binding protein 2 |
135 |
0.96 |
chr4_155085637_155086611 | 3.55 |
Rer1 |
retention in endoplasmic reticulum sorting receptor 1 |
247 |
0.67 |
chr3_129213694_129214733 | 3.55 |
Pitx2 |
paired-like homeodomain transcription factor 2 |
62 |
0.97 |
chr1_57774668_57775682 | 3.55 |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
258 |
0.95 |
chr4_109977849_109978740 | 3.53 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
241 |
0.73 |
chr10_67096114_67097344 | 3.50 |
Reep3 |
receptor accessory protein 3 |
117 |
0.67 |
chr6_53067832_53069023 | 3.50 |
Jazf1 |
JAZF zinc finger 1 |
204 |
0.95 |
chr10_43174435_43174840 | 3.49 |
9030612E09Rik |
RIKEN cDNA 9030612E09 gene |
62 |
0.55 |
chr2_65238028_65239429 | 3.49 |
Cobll1 |
Cobl-like 1 |
7 |
0.5 |
chr12_117533503_117534508 | 3.46 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
117 |
0.97 |
chr2_139677053_139678960 | 3.46 |
Ism1 |
isthmin 1, angiogenesis inhibitor |
172 |
0.66 |
chr5_113993006_113994051 | 3.45 |
Ssh1 |
slingshot protein phosphatase 1 |
239 |
0.89 |
chr9_95405432_95407220 | 3.45 |
Chst2 |
carbohydrate sulfotransferase 2 |
396 |
0.73 |
chr6_122485766_122486276 | 3.44 |
Rimklb |
ribosomal modification protein rimK-like family member B |
418 |
0.77 |
chr2_33130296_33131698 | 3.42 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
389 |
0.84 |
chr9_29412240_29412812 | 3.42 |
Ntm |
neurotrimin |
322 |
0.95 |
chr10_81429712_81431957 | 3.41 |
Nfic |
nuclear factor I/C |
171 |
0.85 |
chr13_103333732_103334394 | 3.40 |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
129 |
0.97 |
chr1_38835547_38836894 | 3.39 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
154 |
0.95 |
chr13_55471184_55472974 | 3.39 |
Mir6944 |
microRNA 6944 |
5697 |
0.08 |
chr15_87624344_87625037 | 3.39 |
Tafa5 |
TAFA chemokine like family member 5 |
540 |
0.87 |
chr12_22622855_22623610 | 3.38 |
Gm40864 |
predicted gene, 40864 |
113 |
0.53 |
chr9_65140883_65141482 | 3.37 |
Igdcc3 |
immunoglobulin superfamily, DCC subclass, member 3 |
7 |
0.97 |
chr14_57525179_57526034 | 3.36 |
Il17d |
interleukin 17D |
829 |
0.55 |
chr17_83214679_83215981 | 3.36 |
Pkdcc |
protein kinase domain containing, cytoplasmic |
38 |
0.98 |
chr14_29722466_29722817 | 3.35 |
Cacna2d3 |
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
777 |
0.62 |
chr1_79858099_79859256 | 3.35 |
Serpine2 |
serine (or cysteine) peptidase inhibitor, clade E, member 2 |
19 |
0.98 |
chr18_24708936_24710320 | 3.34 |
Fhod3 |
formin homology 2 domain containing 3 |
183 |
0.62 |
chr9_107709267_107710507 | 3.34 |
Sema3f |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
132 |
0.92 |
chr4_105109394_105110039 | 3.33 |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
174 |
0.97 |
chr3_125937638_125938666 | 3.31 |
Ugt8a |
UDP galactosyltransferase 8A |
399 |
0.92 |
chr7_114116927_114117657 | 3.30 |
Rras2 |
related RAS viral (r-ras) oncogene 2 |
472 |
0.85 |
chr10_31608510_31609170 | 3.30 |
Rnf217 |
ring finger protein 217 |
344 |
0.88 |
chr5_138995205_138996403 | 3.29 |
Pdgfa |
platelet derived growth factor, alpha |
197 |
0.86 |
chr5_33995599_33996957 | 3.29 |
Nat8l |
N-acetyltransferase 8-like |
294 |
0.82 |
chr6_120492980_120494328 | 3.29 |
Tmem121b |
transmembrane protein 121B |
153 |
0.93 |
chr1_6440931_6441627 | 3.28 |
Gm19026 |
predicted gene, 19026 |
17 |
0.98 |
chr1_34750435_34750828 | 3.27 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
50 |
0.96 |
chr4_24966254_24966983 | 3.26 |
C230012O17Rik |
RIKEN cDNA C230012O17 gene |
2 |
0.49 |
chr7_63757798_63758433 | 3.26 |
Otud7a |
OTU domain containing 7A |
3403 |
0.22 |
chr16_17797113_17797920 | 3.25 |
Scarf2 |
scavenger receptor class F, member 2 |
166 |
0.9 |
chr3_18054686_18055378 | 3.25 |
Bhlhe22 |
basic helix-loop-helix family, member e22 |
858 |
0.62 |
chr7_34655144_34655944 | 3.25 |
Kctd15 |
potassium channel tetramerisation domain containing 15 |
35 |
0.96 |
chr2_92599641_92600412 | 3.24 |
Chst1 |
carbohydrate sulfotransferase 1 |
319 |
0.85 |
chr1_14309545_14310115 | 3.24 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
6 |
0.99 |
chr5_5380210_5380890 | 3.22 |
Cdk14 |
cyclin-dependent kinase 14 |
299 |
0.92 |
chr19_61225302_61226760 | 3.21 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr7_65861740_65862468 | 3.20 |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
32 |
0.59 |
chr12_108554869_108555400 | 3.20 |
Gm16596 |
predicted gene, 16596 |
330 |
0.55 |
chr4_66403446_66404232 | 3.20 |
Astn2 |
astrotactin 2 |
644 |
0.81 |
chr13_78198276_78198655 | 3.20 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
448 |
0.5 |
chr11_114066488_114067724 | 3.19 |
Sdk2 |
sidekick cell adhesion molecule 2 |
60 |
0.98 |
chr4_78211506_78212633 | 3.18 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
108 |
0.5 |
chr13_78198943_78199319 | 3.17 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
607 |
0.42 |
chr4_119356312_119356627 | 3.17 |
Ccdc30 |
coiled-coil domain containing 30 |
3333 |
0.14 |
chr5_112394543_112395027 | 3.16 |
Asphd2 |
aspartate beta-hydroxylase domain containing 2 |
81 |
0.95 |
chr1_155244126_155244829 | 3.15 |
BC034090 |
cDNA sequence BC034090 |
33 |
0.97 |
chr17_8800581_8801529 | 3.15 |
Pde10a |
phosphodiesterase 10A |
638 |
0.79 |
chr10_61783126_61783594 | 3.15 |
Macroh2a2 |
macroH2A.2 histone |
787 |
0.59 |
chr2_28446566_28447382 | 3.14 |
Ppp1r26 |
protein phosphatase 1, regulatory subunit 26 |
108 |
0.95 |
chr4_149586082_149586582 | 3.13 |
Clstn1 |
calsyntenin 1 |
136 |
0.94 |
chr7_99268137_99268951 | 3.13 |
Map6 |
microtubule-associated protein 6 |
138 |
0.92 |
chr14_65953649_65953813 | 3.13 |
Scara3 |
scavenger receptor class A, member 3 |
204 |
0.93 |
chr9_58822128_58823600 | 3.13 |
Hcn4 |
hyperpolarization-activated, cyclic nucleotide-gated K+ 4 |
548 |
0.82 |
chr9_72924923_72926161 | 3.12 |
Pygo1 |
pygopus 1 |
103 |
0.93 |
chr2_163202628_163203658 | 3.12 |
Tox2 |
TOX high mobility group box family member 2 |
18 |
0.98 |
chr10_84533171_84534667 | 3.10 |
Ckap4 |
cytoskeleton-associated protein 4 |
117 |
0.94 |
chr1_192854834_192855905 | 3.09 |
Sertad4 |
SERTA domain containing 4 |
117 |
0.82 |
chr5_146384860_146385320 | 3.09 |
Wasf3 |
WAS protein family, member 3 |
105 |
0.97 |
chr2_102451171_102452295 | 3.08 |
Fjx1 |
four jointed box 1 |
766 |
0.72 |
chr7_133121696_133122677 | 3.07 |
Ctbp2 |
C-terminal binding protein 2 |
14 |
0.95 |
chr11_52098162_52099642 | 3.07 |
Ppp2ca |
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
221 |
0.52 |
chr3_30507827_30509444 | 3.06 |
Mecom |
MDS1 and EVI1 complex locus |
852 |
0.52 |
chr12_26414308_26415459 | 3.05 |
Mir6538 |
microRNA 6538 |
127 |
0.66 |
chr12_107752714_107752867 | 3.05 |
4930465M20Rik |
RIKEN cDNA 4930465M20 gene |
17294 |
0.23 |
chr2_158409115_158410592 | 3.04 |
Ralgapb |
Ral GTPase activating protein, beta subunit (non-catalytic) |
0 |
0.95 |
chr2_165563196_165563907 | 3.03 |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
31481 |
0.13 |
chr18_82169346_82169880 | 3.03 |
Gm50294 |
predicted gene, 50294 |
88897 |
0.07 |
chr3_141464728_141465909 | 3.03 |
Gm15688 |
predicted gene 15688 |
15 |
0.59 |
chr7_112678831_112680131 | 3.02 |
Tead1 |
TEA domain family member 1 |
29 |
0.91 |
chr4_134703673_134704909 | 3.02 |
Man1c1 |
mannosidase, alpha, class 1C, member 1 |
1 |
0.98 |
chr6_119107307_119108229 | 3.02 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
207 |
0.96 |
chr9_87730290_87730964 | 3.01 |
Tbx18 |
T-box18 |
130 |
0.94 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 4.6 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
3.7 | 11.2 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
3.5 | 10.4 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
3.2 | 9.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
2.8 | 2.8 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
2.7 | 8.2 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
2.7 | 8.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
2.6 | 7.9 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
2.5 | 2.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.4 | 12.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.3 | 7.0 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
2.2 | 8.9 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
2.1 | 8.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
2.1 | 10.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
2.1 | 6.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.1 | 6.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.0 | 5.9 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.0 | 5.9 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
1.9 | 5.7 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.9 | 13.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
1.9 | 5.6 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.8 | 5.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
1.8 | 7.4 | GO:0003383 | apical constriction(GO:0003383) |
1.8 | 5.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.8 | 9.1 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
1.8 | 3.6 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
1.8 | 5.4 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.8 | 3.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.7 | 5.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.7 | 1.7 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.7 | 15.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.7 | 1.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.7 | 5.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.7 | 5.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.7 | 5.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.7 | 5.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.6 | 1.6 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.6 | 9.8 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
1.6 | 1.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.6 | 4.8 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
1.6 | 6.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.6 | 7.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.5 | 3.1 | GO:0021564 | vagus nerve development(GO:0021564) |
1.5 | 1.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.5 | 6.1 | GO:0035799 | ureter maturation(GO:0035799) |
1.5 | 4.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.5 | 1.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.5 | 4.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.4 | 4.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.4 | 4.3 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
1.4 | 1.4 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.4 | 5.7 | GO:0021978 | telencephalon regionalization(GO:0021978) |
1.4 | 4.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.4 | 5.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.4 | 4.2 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.4 | 2.8 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
1.4 | 9.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.4 | 4.1 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.4 | 5.4 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
1.4 | 4.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.3 | 4.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.3 | 2.7 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.3 | 6.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.3 | 5.3 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
1.3 | 2.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.3 | 3.9 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.3 | 3.9 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
1.3 | 5.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
1.3 | 3.8 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.3 | 11.4 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
1.3 | 1.3 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.2 | 5.0 | GO:0061743 | motor learning(GO:0061743) |
1.2 | 3.7 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
1.2 | 14.9 | GO:0043586 | tongue development(GO:0043586) |
1.2 | 2.5 | GO:0021557 | oculomotor nerve development(GO:0021557) |
1.2 | 3.7 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.2 | 3.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.2 | 3.6 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.2 | 4.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.2 | 7.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.2 | 3.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.2 | 3.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.2 | 6.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.2 | 1.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
1.2 | 3.5 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.2 | 10.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.2 | 1.2 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.1 | 3.4 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.1 | 3.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.1 | 3.4 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.1 | 3.4 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
1.1 | 3.3 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.1 | 3.3 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.1 | 4.3 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.1 | 2.1 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
1.1 | 8.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.1 | 1.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
1.0 | 5.2 | GO:0035989 | tendon development(GO:0035989) |
1.0 | 3.1 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
1.0 | 4.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.0 | 2.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.0 | 4.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.0 | 4.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.0 | 4.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.0 | 4.1 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.0 | 2.0 | GO:0003160 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
1.0 | 3.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.0 | 3.0 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
1.0 | 3.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.0 | 3.9 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
1.0 | 7.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.0 | 14.6 | GO:0060384 | innervation(GO:0060384) |
1.0 | 1.9 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.9 | 2.7 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.9 | 1.8 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.9 | 0.9 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.9 | 1.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.9 | 0.9 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
0.9 | 3.5 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.9 | 1.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.9 | 3.5 | GO:0060437 | lung growth(GO:0060437) |
0.9 | 0.9 | GO:0060066 | oviduct development(GO:0060066) |
0.9 | 3.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.9 | 1.7 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.9 | 2.6 | GO:0003207 | cardiac chamber formation(GO:0003207) |
0.8 | 0.8 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.8 | 3.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.8 | 2.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.8 | 2.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.8 | 1.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.8 | 3.3 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.8 | 2.5 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.8 | 2.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.8 | 0.8 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.8 | 0.8 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.8 | 4.9 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.8 | 0.8 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.8 | 2.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.8 | 2.4 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.8 | 3.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.8 | 3.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.8 | 1.6 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.8 | 1.5 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.8 | 4.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.8 | 2.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.8 | 3.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.8 | 0.8 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.8 | 3.8 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.7 | 5.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.7 | 0.7 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.7 | 6.7 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.7 | 3.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.7 | 1.5 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.7 | 1.5 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.7 | 2.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.7 | 2.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.7 | 2.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.7 | 1.4 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.7 | 2.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.7 | 4.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.7 | 1.4 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.7 | 19.4 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.7 | 2.8 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.7 | 1.4 | GO:0072104 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.7 | 4.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.7 | 3.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.7 | 6.9 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.7 | 2.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.7 | 2.0 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.7 | 2.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.7 | 2.7 | GO:0060914 | heart formation(GO:0060914) |
0.7 | 2.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.7 | 2.0 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.7 | 1.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.7 | 6.7 | GO:0060013 | righting reflex(GO:0060013) |
0.7 | 12.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.7 | 6.6 | GO:0021854 | hypothalamus development(GO:0021854) |
0.7 | 2.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.7 | 1.3 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.7 | 5.2 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.6 | 2.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 1.9 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.6 | 1.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.6 | 1.9 | GO:0097503 | sialylation(GO:0097503) |
0.6 | 1.9 | GO:0032252 | secretory granule localization(GO:0032252) |
0.6 | 1.9 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.6 | 1.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.6 | 1.9 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.6 | 4.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.6 | 1.9 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.6 | 1.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.6 | 3.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.6 | 1.9 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.6 | 4.3 | GO:0035878 | nail development(GO:0035878) |
0.6 | 0.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.6 | 2.5 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.6 | 1.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.6 | 1.2 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.6 | 0.6 | GO:0007494 | midgut development(GO:0007494) |
0.6 | 1.8 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.6 | 4.9 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.6 | 3.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.6 | 1.2 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.6 | 1.2 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.6 | 1.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.6 | 0.6 | GO:0060129 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.6 | 1.8 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.6 | 7.8 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.6 | 3.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 2.4 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.6 | 3.6 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.6 | 3.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.6 | 1.8 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.6 | 1.2 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.6 | 4.7 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.6 | 1.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.6 | 4.1 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.6 | 1.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.6 | 3.5 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.6 | 7.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.6 | 2.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.6 | 5.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.6 | 5.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.6 | 1.7 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.6 | 1.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.6 | 1.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.6 | 9.6 | GO:0001964 | startle response(GO:0001964) |
0.6 | 2.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 1.7 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.6 | 2.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.5 | 3.8 | GO:0071625 | vocalization behavior(GO:0071625) |
0.5 | 30.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 1.1 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.5 | 2.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.5 | 0.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.5 | 2.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.5 | 0.5 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.5 | 1.6 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.5 | 5.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.5 | 1.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.5 | 0.5 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.5 | 1.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.5 | 0.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.5 | 2.6 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.5 | 4.6 | GO:0001709 | cell fate determination(GO:0001709) |
0.5 | 3.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.5 | 1.5 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.5 | 1.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.5 | 1.5 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.5 | 5.5 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.5 | 1.5 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.5 | 2.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.5 | 3.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.5 | 3.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 0.5 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.5 | 1.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.5 | 1.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.5 | 1.9 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.5 | 1.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.5 | 0.5 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.5 | 1.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 2.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.5 | 1.9 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.5 | 1.4 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.5 | 2.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.5 | 0.5 | GO:0048143 | astrocyte activation(GO:0048143) |
0.5 | 3.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.5 | 0.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.5 | 0.9 | GO:0030035 | microspike assembly(GO:0030035) |
0.5 | 0.9 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.5 | 5.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.5 | 1.9 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.5 | 0.5 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.5 | 1.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 2.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.5 | 1.4 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 0.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.5 | 0.9 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.4 | 1.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.4 | 2.2 | GO:0030578 | PML body organization(GO:0030578) |
0.4 | 1.3 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.4 | 1.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.4 | 4.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 1.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 7.0 | GO:0010842 | retina layer formation(GO:0010842) |
0.4 | 1.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.4 | 2.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.4 | 2.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.4 | 1.3 | GO:0035106 | operant conditioning(GO:0035106) |
0.4 | 0.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.4 | 3.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 1.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.4 | 0.4 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.4 | 1.3 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.4 | 1.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 0.8 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.4 | 1.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.4 | 2.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.4 | 0.4 | GO:0060594 | mammary gland specification(GO:0060594) |
0.4 | 1.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.4 | 3.3 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.4 | 1.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 0.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 0.4 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 4.1 | GO:0007135 | meiosis II(GO:0007135) |
0.4 | 0.8 | GO:0051794 | regulation of catagen(GO:0051794) |
0.4 | 0.8 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.4 | 2.0 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.4 | 2.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.4 | 1.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 0.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.4 | 0.8 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.4 | 3.5 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 1.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.4 | 0.8 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 2.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.4 | 1.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 0.8 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.4 | 0.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.4 | 0.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 10.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.4 | 1.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 0.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.4 | 3.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.4 | 2.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.4 | 0.7 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.4 | 5.5 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.4 | 0.7 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.4 | 0.7 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.4 | 1.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 1.8 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.4 | 0.4 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.4 | 1.8 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.4 | 1.5 | GO:0060004 | reflex(GO:0060004) |
0.4 | 0.7 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 0.4 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.4 | 1.1 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.4 | 1.4 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 1.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 0.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 1.0 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.3 | 1.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 1.4 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 2.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 0.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.3 | 1.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 1.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 2.0 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 1.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 1.3 | GO:0034698 | response to gonadotropin(GO:0034698) cellular response to gonadotropin stimulus(GO:0071371) |
0.3 | 1.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 1.0 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 1.3 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.3 | 0.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.3 | 2.3 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 2.0 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 1.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 2.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 0.3 | GO:0051938 | L-glutamate import(GO:0051938) |
0.3 | 0.3 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.3 | 2.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 0.3 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.3 | 2.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 1.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 1.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 1.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.3 | 1.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 1.0 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.3 | 1.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.3 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 1.9 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 0.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 3.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.9 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.3 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 0.3 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 3.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 0.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 0.6 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.3 | 1.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 3.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 0.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 1.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 0.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 1.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 0.3 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.3 | 0.6 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.3 | 0.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.3 | 2.4 | GO:0060065 | uterus development(GO:0060065) |
0.3 | 0.6 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 0.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 0.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 0.9 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 0.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 1.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 2.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 2.6 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.3 | 0.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 0.6 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.3 | 0.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 1.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.3 | 1.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.3 | 0.3 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.3 | 0.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 2.8 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.3 | 0.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 0.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.3 | 0.8 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.3 | 1.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 0.8 | GO:0048665 | neuron fate specification(GO:0048665) |
0.3 | 18.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 2.2 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.3 | 0.8 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.3 | 2.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.3 | 0.6 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 1.6 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 1.9 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.3 | 0.3 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.3 | 0.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.3 | 0.3 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.3 | 2.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.3 | 3.6 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.3 | 0.8 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 0.3 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.3 | 1.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 0.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 0.5 | GO:2001053 | regulation of mesenchymal cell apoptotic process(GO:2001053) |
0.3 | 1.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 0.5 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 1.7 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 0.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.2 | 0.5 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.7 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 1.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 1.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.2 | 1.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.7 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.2 | 1.2 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.2 | 0.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.2 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.2 | 0.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 1.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.9 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.2 | 0.2 | GO:0060435 | bronchiole development(GO:0060435) |
0.2 | 0.7 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 1.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 23.0 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 0.9 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.2 | 0.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 0.9 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.2 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.4 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 3.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.7 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 6.7 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 1.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 7.1 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.2 | 0.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 2.6 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 0.2 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 0.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 0.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 1.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.6 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 1.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.6 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 0.4 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 1.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 1.9 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 0.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 1.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 1.2 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 1.2 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 0.8 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 2.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 0.2 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.2 | 1.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.2 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.2 | 0.8 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) |
0.2 | 0.6 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 0.4 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 0.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.4 | GO:0046909 | intermembrane transport(GO:0046909) |
0.2 | 1.4 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 0.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 0.4 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.4 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.2 | 0.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.2 | 1.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 1.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.6 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.2 | 0.2 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.2 | 0.4 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 1.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.4 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 1.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.2 | 1.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 1.3 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.2 | 0.4 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 2.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 0.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.4 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 1.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.4 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.2 | 0.2 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 0.4 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 1.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.2 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.2 | 0.2 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 0.5 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.2 | 0.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 0.5 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 1.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.8 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.2 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 0.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.2 | 1.0 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.2 | 0.3 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.2 | 0.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 1.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 1.9 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 1.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 0.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.2 | 0.3 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 1.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.3 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.2 | 0.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.8 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 2.0 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.2 | 2.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 0.3 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 0.2 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.2 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 1.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.8 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 1.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.8 | GO:0036035 | osteoclast development(GO:0036035) |
0.2 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 3.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.3 | GO:2000679 | positive regulation of transcription regulatory region DNA binding(GO:2000679) |
0.2 | 0.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 1.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.2 | 0.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 0.3 | GO:1904396 | regulation of neuromuscular junction development(GO:1904396) |
0.2 | 1.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.2 | 0.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 6.5 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.1 | 0.6 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 2.4 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.7 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.1 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.1 | 0.6 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.1 | 0.3 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.1 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.7 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.1 | 0.1 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.1 | 0.1 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.3 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.1 | 0.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 1.2 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.5 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.4 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 9.4 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.1 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.1 | 0.4 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 0.1 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.1 | 0.4 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.1 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 2.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.5 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.4 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 1.1 | GO:0035094 | response to nicotine(GO:0035094) |
0.1 | 0.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.4 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 2.2 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 2.1 | GO:0071475 | cellular response to salt stress(GO:0071472) cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.1 | GO:0003171 | atrioventricular valve development(GO:0003171) |
0.1 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.9 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.1 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 2.0 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.1 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 1.8 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 1.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.2 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.2 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 3.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 3.5 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.1 | 0.5 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.9 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 1.9 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.1 | 0.2 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.2 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.1 | GO:0072017 | distal tubule development(GO:0072017) |
0.1 | 0.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.6 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.1 | 1.6 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.1 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
0.1 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 2.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 1.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 1.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.4 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.1 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.1 | GO:0072044 | collecting duct development(GO:0072044) |
0.1 | 0.3 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.6 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.2 | GO:0043217 | myelin maintenance(GO:0043217) |
0.1 | 0.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.1 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.1 | 0.8 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.4 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 2.3 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.2 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 1.7 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.4 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.1 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 1.4 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.5 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.6 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.8 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
0.1 | 4.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 3.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.1 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.2 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.1 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.1 | GO:0071220 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
0.1 | 0.4 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.7 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.1 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.1 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.1 | GO:0021545 | cranial nerve development(GO:0021545) |
0.1 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 | 0.7 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.1 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.1 | 0.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 1.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.2 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.1 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.1 | 1.9 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.1 | 0.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 1.2 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.8 | GO:0042755 | eating behavior(GO:0042755) |
0.1 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.2 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
0.1 | 0.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.1 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.5 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.3 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.1 | 0.1 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.1 | 0.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0042851 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.6 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.1 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.1 | 0.1 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.9 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.1 | GO:0072087 | renal vesicle development(GO:0072087) |
0.1 | 0.1 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.2 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.3 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.0 | 0.1 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.3 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.0 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 1.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 1.3 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.0 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.0 | 0.6 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.0 | 0.0 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.0 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.0 | 0.2 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.2 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.0 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.0 | 2.2 | GO:0030178 | negative regulation of Wnt signaling pathway(GO:0030178) |
0.0 | 0.6 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.2 | GO:0010522 | regulation of calcium ion transport into cytosol(GO:0010522) |
0.0 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.5 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.0 | 0.1 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.0 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.2 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.3 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.4 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.2 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.0 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.0 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.3 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.0 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.2 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) |
0.0 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 2.4 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.4 | GO:0048565 | digestive tract development(GO:0048565) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.0 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.0 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
0.0 | 0.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.1 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.2 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) peristalsis(GO:0030432) |
0.0 | 0.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.1 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.1 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.0 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.0 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.0 | GO:2000855 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.0 | 0.0 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.0 | 0.1 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
0.0 | 0.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.0 | 0.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.0 | 0.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.0 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.0 | 0.0 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.0 | 0.0 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.0 | 0.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.0 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
0.0 | 0.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.0 | 0.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 2.8 | GO:0097470 | ribbon synapse(GO:0097470) |
1.8 | 1.8 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.8 | 10.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.6 | 4.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.4 | 4.1 | GO:0097427 | microtubule bundle(GO:0097427) |
1.3 | 5.3 | GO:0033269 | internode region of axon(GO:0033269) |
1.3 | 3.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.1 | 3.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.0 | 2.9 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.0 | 3.9 | GO:0032437 | cuticular plate(GO:0032437) |
0.9 | 4.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.9 | 0.9 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.8 | 1.7 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.8 | 4.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.8 | 14.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.8 | 9.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.8 | 4.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.8 | 2.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.8 | 3.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 3.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.8 | 2.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.8 | 0.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.8 | 4.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.8 | 12.8 | GO:0030673 | axolemma(GO:0030673) |
0.7 | 21.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.7 | 14.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 2.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 2.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.7 | 8.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.7 | 2.7 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 4.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.6 | 1.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.6 | 0.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 1.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.6 | 10.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.6 | 5.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.6 | 36.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.5 | 0.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.5 | 1.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.5 | 4.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 1.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 3.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 1.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 1.9 | GO:0032021 | NELF complex(GO:0032021) |
0.5 | 2.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.5 | 2.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.5 | 11.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 1.9 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 1.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 6.7 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 4.5 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 3.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 5.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.4 | 1.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 2.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 5.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.4 | 13.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 2.4 | GO:0001652 | granular component(GO:0001652) |
0.4 | 0.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 1.6 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.4 | 32.9 | GO:0005604 | basement membrane(GO:0005604) |
0.4 | 1.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 2.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 4.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 3.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 1.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.4 | 0.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 1.4 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 3.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 2.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 44.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 1.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.3 | 1.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 1.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 2.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 3.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 57.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 1.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.3 | 8.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 1.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.3 | 1.7 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.3 | 5.6 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 0.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 2.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 3.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 0.8 | GO:1990696 | USH2 complex(GO:1990696) |
0.3 | 0.5 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 2.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 3.8 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 0.5 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 1.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 12.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 12.7 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 0.5 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 1.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 2.9 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 1.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 26.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 0.6 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 1.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.2 | 5.1 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 1.3 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 16.4 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 0.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.6 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 2.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 2.6 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 0.5 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 2.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 4.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 4.9 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 1.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 9.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 1.4 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 1.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 7.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 7.3 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 8.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.9 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 9.9 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 3.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.5 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 1.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.7 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 1.2 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 1.5 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 3.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 60.0 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.1 | GO:0070160 | occluding junction(GO:0070160) |
0.1 | 0.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.3 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 47.8 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 155.6 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 1.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 1.2 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 1.8 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 8.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.2 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.0 | 0.1 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.0 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 9.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.9 | 5.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.8 | 5.5 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.7 | 5.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.6 | 4.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.6 | 6.3 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.5 | 4.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.5 | 2.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.4 | 5.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.4 | 4.2 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.3 | 6.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.3 | 3.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.3 | 3.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.3 | 5.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.2 | 7.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.2 | 3.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.2 | 3.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.2 | 3.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.2 | 4.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.2 | 3.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.2 | 3.5 | GO:0030553 | cGMP binding(GO:0030553) |
1.1 | 3.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.0 | 5.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.0 | 3.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.0 | 3.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.0 | 10.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.0 | 3.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 5.7 | GO:0038132 | neuregulin binding(GO:0038132) |
0.9 | 28.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.9 | 2.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.9 | 13.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.9 | 23.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.9 | 3.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.9 | 2.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.9 | 3.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.9 | 4.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.9 | 2.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.9 | 1.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.9 | 2.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.9 | 10.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.8 | 3.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.8 | 2.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.8 | 5.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.8 | 2.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.8 | 2.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.8 | 3.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.8 | 23.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.8 | 22.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.8 | 3.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.8 | 2.3 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 3.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.7 | 5.1 | GO:0043495 | protein anchor(GO:0043495) |
0.7 | 10.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.7 | 8.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.7 | 2.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.7 | 2.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 3.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.6 | 3.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.6 | 5.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 19.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.6 | 3.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.6 | 10.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.6 | 1.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.6 | 1.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.6 | 0.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 1.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 1.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.6 | 2.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.6 | 6.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.6 | 7.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.6 | 2.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.6 | 2.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.6 | 9.5 | GO:0005112 | Notch binding(GO:0005112) |
0.6 | 1.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.6 | 2.2 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.6 | 2.8 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.5 | 10.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.5 | 1.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.5 | 2.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 2.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 2.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 5.9 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 2.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 2.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 1.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.5 | 1.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.5 | 6.3 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.5 | 3.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 1.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.5 | 1.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 2.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 17.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.5 | 1.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.5 | 1.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 5.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.5 | 3.4 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.5 | 1.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 0.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.5 | 1.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.5 | 6.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 13.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.5 | 1.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 1.4 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 3.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.4 | 1.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 4.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 1.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.4 | 5.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.4 | 1.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.4 | 3.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 16.9 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.4 | 1.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 2.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 4.9 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 1.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 5.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 2.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 2.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 5.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.4 | 16.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.4 | 1.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 2.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.4 | 5.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 1.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 1.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 0.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 1.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.4 | 1.9 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.4 | 4.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 1.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 1.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 7.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.4 | 5.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 2.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.4 | 1.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 11.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 6.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 1.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 3.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 3.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.3 | 1.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 3.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 3.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 2.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 2.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 0.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.3 | 0.6 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 2.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 4.8 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.3 | 1.0 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.3 | 3.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 71.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.3 | 1.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 9.5 | GO:0070888 | E-box binding(GO:0070888) |
0.3 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 29.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 2.6 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 1.7 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.3 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 4.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 2.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 1.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 1.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 2.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 1.1 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 0.8 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 4.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 1.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 4.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 1.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 14.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 0.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 1.3 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.3 | 0.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 1.7 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 1.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 1.7 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 1.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 1.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 1.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.7 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 5.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 1.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 0.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.2 | 0.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 2.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 12.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.9 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 1.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 0.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 1.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 1.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 5.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 2.4 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 1.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 1.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 0.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 3.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 3.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 1.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 0.6 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 5.1 | GO:0005267 | potassium channel activity(GO:0005267) |
0.2 | 1.5 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.2 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.4 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.2 | 0.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 2.3 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 2.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 1.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 0.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 8.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 0.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 5.4 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.2 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 0.9 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.7 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.2 | 1.2 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 3.0 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 1.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 8.9 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 3.8 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 6.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 4.3 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 1.0 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.2 | 0.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 1.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 13.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 1.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 10.0 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.8 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 0.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 1.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.2 | 11.8 | GO:0008083 | growth factor activity(GO:0008083) |
0.2 | 0.6 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 1.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 1.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 1.5 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 4.5 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 3.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 4.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 2.4 | GO:0044654 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.1 | 1.7 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.3 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.4 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 9.9 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 5.7 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 1.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 10.1 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.1 | 0.5 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 30.4 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 1.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.9 | GO:0018855 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.3 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.2 | GO:0015265 | urea transmembrane transporter activity(GO:0015204) urea channel activity(GO:0015265) |
0.1 | 3.6 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 2.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.4 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.3 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 0.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 1.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 3.4 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.3 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 2.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.7 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.9 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 1.1 | GO:0005231 | excitatory extracellular ligand-gated ion channel activity(GO:0005231) |
0.1 | 0.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 23.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.6 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 1.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 12.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.4 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 1.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 2.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.1 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 1.2 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.0 | 0.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.0 | 15.4 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 0.2 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 2.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 1.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.4 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 1.0 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.1 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 1.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.0 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.0 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.3 | GO:0052767 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 9.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.8 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.8 | 11.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.8 | 5.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.6 | 3.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.6 | 22.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.6 | 17.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.6 | 8.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 17.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.6 | 12.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 4.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 2.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.5 | 16.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.5 | 2.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 33.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.4 | 5.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 4.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 3.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 7.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 6.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 5.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 2.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 1.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 7.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 4.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 1.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 2.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 0.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 38.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 12.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 6.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 2.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 1.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 6.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 1.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 35.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 50.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 2.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 7.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 1.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 8.6 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 5.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 1.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 2.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 1.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 6.2 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 3.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 2.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 5.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 3.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 4.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 1.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 0.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 2.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 32.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 4.0 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 2.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 2.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 1.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 11.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.0 | 10.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
1.0 | 1.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.9 | 10.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.8 | 15.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.8 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.8 | 20.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.7 | 7.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.7 | 30.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.7 | 7.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.7 | 5.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 3.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.6 | 13.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.6 | 7.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.6 | 7.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 7.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 6.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.5 | 13.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.5 | 18.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 5.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.5 | 6.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 4.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 4.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 6.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 2.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 9.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 14.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 6.6 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.4 | 5.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 9.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.4 | 14.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 1.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 4.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 7.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 5.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 1.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 2.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 7.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 3.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 3.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 4.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.3 | 4.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 1.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.3 | 2.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 20.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 4.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 10.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 3.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 1.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 3.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 21.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 2.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 2.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 4.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 3.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 1.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.8 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 1.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 4.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.2 | 1.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 1.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 3.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 2.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 1.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 4.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 3.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 1.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 0.9 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 1.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 5.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.1 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 0.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 10.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 1.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.7 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 7.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 0.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 0.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.4 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 1.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 3.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 0.2 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 3.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.0 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 1.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.0 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |